Primary Sjogren's syndrome associated neuropathy

被引:32
作者
Mellgren, Svein Ivar
Goransson, Lasse G.
Omdal, Roald
机构
[1] Univ Tromso, Univ Tromso Hosp, Inst Clin Med, Dept Neurol, Tromso, Norway
[2] Stavanger Univ Hosp, Dept Internal Med, Clin Immunol Unit, Stavanger, Norway
[3] Univ Bergen, Inst Internal Med, N-5020 Bergen, Norway
关键词
D O I
10.1017/S0317167100006697
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Primary Sjogren's syndrome (PSS) mainly affects exocrine glands and is clinically characterized by keratoconjunctivitis sicca and xerostomia. Among several possible extraglandular manifestations, involvement of the peripheral nervous system may occur with reported frequencies from 10% to 60%. Peripheral nerve manifestations constitute sensory neuropathy, including sensory ganglioneuronopathy, sensorimotor, including polyradiculoneuropathy and demyelinating neuropathy, motor neuropathy, multiple mononeuropathy, trigeminal and other cranial neuropathies, autonomic neuropathy, and mixed patterns of neuropathy. Knowledge of the neurological manifestations of PSS is hampered by evolving classification criteria of PSS over the years, and by use of highly selected patient populations on the basis of a primary neurological diagnosis. Sural nerve biopsy may show vascular or perivascular inflammation of small epineurial vessels (both arterioles and venules) and in some cases necrotizing vasculitis. Loss of myelinated nerve fibers is common and loss of small diameter nerve fibers occurs. Pathology in cases of sensory ganglioneuronopathy consists of loss of neuronal cell bodies and infiltration of T cells. Peripheral neuropathy in PSS often is refractory to treatment although newer biological agents may provide more effective treatment options. Current treatment strategies used in autoimmune neuropathies may be tried depending upon characteristics of the neuropathy and results obtained by a thorough clinical and laboratory investigation.
引用
收藏
页码:280 / 287
页数:8
相关论文
共 49 条
[1]   NEUROLOGIC COMPLICATIONS OF PRIMARY SJOGRENS SYNDROME [J].
ALEXANDER, EL ;
PROVOST, TT ;
STEVENS, MB ;
ALEXANDER, GE .
MEDICINE, 1982, 61 (04) :247-257
[2]  
ANDONOPOULOS AP, 1990, BRIT J RHEUMATOL, V29, P21
[3]  
Barendregt PJ, 2001, ANN RHEUM DIS, V60, P876
[4]   Severe sensory neuronopathy responsive to infliximab in primary Sjogren's syndrome [J].
Caroyer, JM ;
Manto, MU ;
Steinfeld, SD .
NEUROLOGY, 2002, 59 (07) :1113-1114
[5]   Painful small-fiber neuropathy in Sjogren syndrome [J].
Chai, J ;
Herrmann, DN ;
Stanton, M ;
Barbano, RL ;
Logigian, EL .
NEUROLOGY, 2005, 65 (06) :925-927
[6]   Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sjogren's syndrome [J].
Chen, WH ;
Yeh, JH ;
Chiu, HC .
EUROPEAN NEUROLOGY, 2001, 45 (04) :270-274
[7]   Neurologic manifestations in primary Sjogren syndrome - A study of 82 patients [J].
Delalande, S ;
de Seze, J ;
Fauchais, AL ;
Hachulla, E ;
Stojkovic, T ;
Ferriby, D ;
Dubucquoi, S ;
Pruvo, JP ;
Vermersch, P ;
Hatron, PY .
MEDICINE, 2004, 83 (05) :280-291
[8]   The clinical heterogeneity of immune sensory and autonomic neuropathies with (or without) sicca [J].
Dyck, PJ .
BRAIN, 2005, 128 :2480-2482
[9]   Sjogren's syndrome [J].
Fox, RI .
LANCET, 2005, 366 (9482) :321-331
[10]   SJOGRENS-SYNDROME - PROPOSED CRITERIA FOR CLASSIFICATION [J].
FOX, RI ;
ROBINSON, CA ;
CURD, JG ;
KOZIN, F ;
HOWELL, FV .
ARTHRITIS AND RHEUMATISM, 1986, 29 (05) :577-585